Page 187 Cite

Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2021. The Critical Public Health Value of Vaccines: Tackling Issues of Access and Hesitancy: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26134.

×

Appendix B

Workshop Agenda

The Critical Public Health Value of Vaccines—Tackling Issues of Access and Hesitancy: A Virtual Meeting

MONDAY, AUGUST 17, 2020

11:00 a.m. ET	Welcome Remarks Peter Daszak, EcoHealth Alliance
	Workshop Overview and Goals Heidi Larson, Vaccine Confidence Project
	Keynote Addresses
	The Global Impact of COVID-19 on Vaccination Uptake and Access Ann Lindstrand, Department of Immunization and Biologicals, World Health Organization
	The Global State of Vaccine Confidence: How Do We Enhance the Uptake of Vaccines? Saad B. Omer, Yale Institute for Global Health
11:45 a.m.	Q&A

Page 188 Cite

Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2021. The Critical Public Health Value of Vaccines: Tackling Issues of Access and Hesitancy: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26134.

×

Session I: Improving Access and Closing the Global Immunization Gap

	Noni MacDonald, Dalhousie University, Moderator
12:00 p.m.	Applying an Equity Lens in Immunization to Close the Global Immunization Gap Anuradha Gupta, Gavi, the Vaccine Alliance
	Reducing Barriers and Increasing Vaccine Uptake Litjen (L. J.) Tan, Immunization Action Coalition
	Case Presentations Using mHealth Interventions to Improve Vaccination Coverage Momin Abdul Kazi, Aga Khan University, Pakistan
	The Role of Community-Based Pharmacy Interventions in Increasing Vaccine Access Jeffery Goad, Department of Pharmacy Practice, Chapman University School of Pharmacy
1:00 p.m.	Q&A
1:45 p.m.	Observations from Day 1 Heidi Larson, Vaccine Confidence Project
2:00 p.m.	Adjourn

TUESDAY, AUGUST 18, 2020

Session II: Assessing Global and Local Drivers of Vaccine Hesitancy

10:00 a.m. ET	Welcome and Recap of Day 1 Matthew Zahn, Orange County Health Care Agency
	Alison Buttenheim, University of Pennsylvania, Moderator
	Case Presentation

Page 189 Cite

Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2021. The Critical Public Health Value of Vaccines: Tackling Issues of Access and Hesitancy: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26134.

×

	Vaccine-Attributable Severe Dengue in the Philippines and the Impact on National Immunization Programs Stefan Flasche, London School of Hygiene & Tropical Medicine
	Measuring Behavioral and Social Drivers of Vaccination Julie Leask, University of Sydney, Australia
	Understanding Drivers of Vaccine Hesitancy Julie Bettinger, Vaccine Evaluation Center, The University of British Columbia
	The Increasing Vaccination Model Noel Brewer, Gillings School of Global Public Health and Lineberger Comprehensive Cancer Center, University of North Carolina
11:00 a.m.	Q&A
11:45 a.m.	Observations from Day 2 Matthew Zahn, Orange County Health Care Agency
12:00 p.m.	Adjourn

WEDNESDAY, AUGUST 19, 2020

Session III: Employing a Systems Approach to Building Confidence and Increasing Uptake

Part A:

10:00 a.m. ET	Welcome and Recap of Day 2 Walter Orenstein, Emory Vaccine Center
	Chandy C. John, Indiana University School of Medicine, Moderator
	Legal Approaches to Promoting Parental Compliance with Childhood Immunization Recommendations Dorit Reiss, University of California Hastings College of the Law

Page 190 Cite

Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2021. The Critical Public Health Value of Vaccines: Tackling Issues of Access and Hesitancy: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26134.

×

	Impact of Eliminating Nonmedical Exemptions in California Michelle Mello, Stanford University
	Harnessing Cultural Insights to Increase Vaccination Uptake and Compliance Dan Carucci, McCann Health
	The Role of Physicians in Building Vaccine Confidence and Acceptance Todd Wolynn, Kids Plus Pediatrics
	Strategies for Improving Health Care Providers’ Communication About Vaccination Sean O’Leary, University of Colorado Denver
12:00 p.m.	Q&A

Part B:

	Rafael Obregon, United Nations Children’s Fund, Paraguay, Moderator
12:30 p.m.	Social Mobilization as a Strategy to Increase Vaccine Acceptance and Uptake Mohamed Jalloh, U.S. Centers for Disease Control and Prevention
	Adaptation of the COM-B Model to Increase Vaccination Acceptance and Uptake: The Tailoring Immunization Programmes Approach Catherine Jackson, Valid Research Limited
	The Immunity Community: A Community Engagement Strategy to Boost Vaccine Confidence Clarissa Hsu, Kaiser Permanente Washington Health Research Institute
	Engaging with Faith Communities to Increase Vaccine Acceptance and Uptake: A Charedi Orthodox Jewish Community Example Louise Letley, Public Health England

Page 191 Cite

Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2021. The Critical Public Health Value of Vaccines: Tackling Issues of Access and Hesitancy: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26134.

×

	Engaging with Immigrant Communities to Increase Vaccine Acceptance and Uptake: A Somali American Community Example Patricia (Patsy) Stinchfield, Children’s Minnesota
1:25 p.m.	Q&A
1:55 p.m.	Observations from Day 3 Walter Orenstein, Emory Vaccine Center
2:00 p.m.	Adjourn

THURSDAY, AUGUST 20, 2020

Session IV: Moving Forward: Optimizing the Utilization of Vaccines

Part A:

11:00 a.m. ET	Welcome and Recap of Day 3 Kent Kester, Sanofi Pasteur
11:00 a.m. ET	Kent Kester, Sanofi Pasteur, Moderator
11:10 a.m.	Plenary Presentation New Vaccines in the Midst of an Outbreak Nicole Lurie, Coalition for Epidemic Preparedness Innovations
11:25 a.m.	Q&A

Part B:

	Panel on Inoculating Against Misinformation and Rebuilding the Public’s Trust in Science Alison Buttenheim, University of Pennsylvania, Moderator
11:45 a.m.	Sander van der Linden, Cambridge Social Decision-Making Laboratory Imran Khan, Wellcome Trust Ethan Lindenberger, Activist Kasisomayajula Viswanath, Harvard T.H. Chan School of Public Health

Page 192 Cite

Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2021. The Critical Public Health Value of Vaccines: Tackling Issues of Access and Hesitancy: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26134.

×

	Visionary Statements of Priorities in Building Vaccine Acceptance and Uptake for the Next Generation Amanda Cohn, U.S. Centers for Disease Control and Prevention, Moderator
12:30 p.m.	Peter Hotez, Baylor College of Medicine Narendra Arora, Inclen Monika Naus, Communicable Diseases and Immunization Service, British Columbia Centre for Disease Control Jean-Marc Olivé, Independent Consultant
12:55 p.m.	Panel Discussion and Audience Q&A
1:20 p.m.	Closing Remarks Peter Daszak, EcoHealth Alliance
1:30 p.m.	Adjourn